Send us Feedback

Cornerstone Therapeutics (CRTX)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Cornerstone (CRTX) Acquires U.S. Marketing Rights to PERTZYE
StreetInsider.com  May 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cornerstone+%28CRTX%29+Acquires+U.S.+Marketing+Rights+to+PERTZYE/8320359.html for the full story.
Cornerstone Therapeutics, Inc. (CRTX) Posts Q4 Loss of 26c/Share
StreetInsider.com  Mar 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cornerstone+Therapeutics%2C+Inc.+%28CRTX%29+Posts+Q4+Loss+of+26cShare/8184190.html for the full story.
Benzinga's Small Cap Movers for Wednesday February 20, 2013
Benzinga  Feb 21  Comment 
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: Cornerstone Therapeutics Shares of Cornerstone Therapeutics (NASDAQ: CRTX), the Cary, NC specialty pharmaceutical company, rose 24% Wednesday on...
Cornerstone Therapeutics, Inc. (CRTX) Misses Q3 EPS by 13c
StreetInsider.com  Nov 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cornerstone+Therapeutics%2C+Inc.+%28CRTX%29+Misses+Q3+EPS+by+13c/7856065.html for the full story.
FDA spurns new low-sodium drug from Cornerstone
FierceBiotech  Nov 1  Comment 
Cornerstone Therapeutics ($CRTX) may not have landed quite the deal it thought it had when it bought Cardiokine and its late-stage drug lixivaptan for a mere $1 million down. After getting shot down by a panel of outside experts, the biotech...
Cornerstone (CRTX) Gets CRL from FDA for Lixivaptan
StreetInsider.com  Nov 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cornerstone+%28CRTX%29+Gets+CRL+from+FDA+for+Lixivaptan/7834053.html for the full story.
Cornerstone (CRTX) Receives FDA Approval for Bethkis NDA; Currently in Licensing Talks
StreetInsider.com  Oct 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cornerstone+%28CRTX%29+Receives+FDA+Approval+for+Bethkis+NDA%3B+Currently+in+Licensing+Talks/7802955.html for the full story.
Notable 52-Week Highs and Lows of the Day 09/13: (CUR) (SNSS) (KEY) High; (MKTS) (SAPX) (CRTX) Low
StreetInsider.com  Sep 13  Comment 
This report is an intraday check of some of the more notable stocks that have hit a 52-week high or low so far today. 52-Week High: Neuralstem, Inc. (AMEX: CUR) high of $1.96. Neuralstem ripping today following data from a study of NSI-566 on...
UPDATE: Cornerstone (CRTX) Says FDA Committee Recommends Against Lixivaptan NDA Approval
StreetInsider.com  Sep 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/UPDATE%3A+Cornerstone+%28CRTX%29+Says+FDA+Committee+Recommends+Against+Lixivaptan+NDA+Approval/7725644.html for the full story.
UPDATED: FDA panel rejects Cornerstone Therapeutics' heart drug
FierceBiotech  Sep 13  Comment 
Cornerstone Therapeutics ($CRTX) was dealt a severe setback today, losing an FDA panel vote on whether their new drug for treating low sodium in the blood should be approved. The agency's outside experts voted 5 to 3 against an approval for...
Cornerstone Falls After U.S. Panel Rejects Low-Salt Drug
Bloomberg  Sep 13  Comment 




more ▼WIKI ANALYSIS
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800.
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Cornerstone_Therapeutics_(CRTX)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki